Carmine Zoccali
Statistics and Probability · 2001–2021
A researcher in the Science corpus: 9 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 32 citations into it
- Cardiology and Cardiovascular Medicine — 19 citations into it
- Economics and Econometrics — 14 citations into it
- Epidemiology — 9 citations into it
- Endocrinology, Diabetes and Metabolism — 6 citations into it
Whom Carmine Zoccali trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Carmine Zoccali's perspective
Ordered by how strongly the researchers Carmine Zoccali trusts endorse each paper. Same corpus, a different order for every researcher.
- Risk prediction models: II. External validation, model updating, and impact assessment (Heart)
- External validation of a Cox prognostic model: principles and methods (BMC Medical Research Methodology)
- Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. (Clinical Chemistry)
- What do we mean by validating a prognostic model? (Statistics in Medicine)
- Constructing inverse probability weights for marginal structural models. (American Journal of Epidemiology)
- Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction (Circulation)
- Estimating causal effects of treatments in randomized and nonrandomized studies.
- Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.
- Sample size considerations for the external validation of a multivariable prognostic model: a resampling study (Statistics in Medicine)
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples (Statistics in Medicine)
Their papers
- An introduction to inverse probability of treatment weighting in observational research (2021) — 789 citations
- External validation of prognostic models: what, why, how, when and where? (2020) — 719 citations
- A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. (2019) — 617 citations
- A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. (2019) — 897 citations
- When do we need competing risks methods for survival analysis in nephrology? (2013) — 628 citations
- Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. (2005) — 601 citations
- Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003) — 814 citations
- Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. (2002) — 813 citations
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. (2001) — 1,108 citations